Global Markets Direct is a cutting-edge provider of market research and business consultancies for a wide range of customers worldwide.
A team of analytics is capable to produce all sorts of market information and carry out extensive industry research using unique data and reliable sources to let customers know who they are at the market. Global Markets Direct has profound analytical experience in researching the industries and preparing customized reports across many specific fields.
The company is distinguished by its high-quality consulting products and close inspection of the issues under study. Diligent efforts of the experts make every piece of business information an exclusive source of feasible solutions and valuable advice.
With a commitment to serve every client need, Global Markets Direct collects and interprets the materials for the analysis, uses methods of primary and secondary research and develops one of a kind data packages for global clients. They are able to cover the tones of industry-related information to assist customers in taking the right business decisions and developing their strategic plans.
Under the supervision of skillful managers and experts, business analysts produce reports that include:
- Product portfolio
- Potentially strong market reviews
- Competitive analytics
- Prospect partners
- Mergers and acquisitions project data
- Latest trends across a particular industry area
- Research and development strategies
- The analysis of new customers
- A set of remedial measures for projects
They will search for new partners and highlight the current business issues plus develop new strategies and tactical steps to help you take the lead in the industry where you operate.
Publications found:
5,853
Sort by:
Melanocortin Receptor 4 - Pipeline Review, H1 2020
US$ 3,500.00
Melanocortin Receptor 4 - Pipeline Review, H1 2020 SUMMARY Melanocortin Receptor 4 (MC4R) - Melanocortin 4 receptor (MC4R) is a G protein-coupled receptor involved in the hypothalamic leptin-melanoc...
April 2020
83 pages
Nociceptin Receptor - Pipeline Review, H1 2020
US$ 3,500.00
Nociceptin Receptor - Pipeline Review, H1 2020 SUMMARY Nociceptin Receptor (Kappa Type 3 Opioid Receptor or KOR3 or Orphanin FQ Receptor or OPRL1) pipeline Target constitutes close to 16 molecules....
April 2020
52 pages
Orexin Receptor Type 1 - Pipeline Review, H1 2020
US$ 3,500.00
Orexin Receptor Type 1 - Pipeline Review, H1 2020 SUMMARY According to the recently published report 'Orexin Receptor Type 1 - Pipeline Review, H1 2020'; Orexin Receptor Type 1 (Hypocretin Receptor...
April 2020
80 pages
Orexin Receptor Type 2 - Pipeline Review, H1 2020
US$ 3,500.00
Orexin Receptor Type 2 - Pipeline Review, H1 2020 SUMMARY Orexin Receptor Type 2 (Hypocretin Receptor Type 2 or HCRTR2) pipeline Target constitutes close to 9 molecules. Out of which approximately 8...
April 2020
83 pages
Placenta Growth Factor - Pipeline Review, H1 2020
US$ 3,500.00
Placenta Growth Factor - Pipeline Review, H1 2020 SUMMARY Placenta Growth Factor (Vascular Endothelial Growth Factor Related Protein or PGF) pipeline Target constitutes close to 21 molecules. The la...
April 2020
88 pages
Retinoic Acid Receptor Alpha - Pipeline Review, H1 2020
US$ 3,500.00
Retinoic Acid Receptor Alpha - Pipeline Review, H1 2020 SUMMARY Retinoic Acid Receptor Alpha (RAR Alpha or Nuclear Receptor Subfamily 1 Group B Member 1 or NR1B1 or RARA) - Retinoic acid receptor al...
April 2020
76 pages
Retinoic Acid Receptor Gamma - Pipeline Review, H1 2020
US$ 3,500.00
Retinoic Acid Receptor Gamma - Pipeline Review, H1 2020 SUMMARY According to the recently published report 'Retinoic Acid Receptor Gamma - Pipeline Review, H1 2020'; Retinoic Acid Receptor Gamma (RA...
April 2020
82 pages
Superoxide Dismutase [Cu-Zn] - Pipeline Review, H1 2020
US$ 3,500.00
Superoxide Dismutase [Cu-Zn] - Pipeline Review, H1 2020 SUMMARY Superoxide Dismutase [Cu-Zn] (Superoxide Dismutase 1 or Epididymis Secretory Protein Li 44 or SOD1 or EC 1.15.1.1) pipeline Target con...
April 2020
72 pages
Type 2 Angiotensin II Receptor - Pipeline Review, H1 2020
US$ 3,500.00
Type 2 Angiotensin II Receptor - Pipeline Review, H1 2020 SUMMARY Type 2 Angiotensin II Receptor (Angiotensin II Type 2 Receptor or AGTR2) pipeline Target constitutes close to 10 molecules. Out of w...
April 2020
55 pages
Uveitis - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Uveitis (Ophthalmology) pipeline guide also reviews of key players involved in therapeutic development for Uveitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
March 2020
259 pages
Celiac Disease - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Celiac Disease (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Celiac Disease and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
March 2020
85 pages
Glaucoma - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Glaucoma (Ophthalmology) pipeline guide also reviews of key players involved in therapeutic development for Glaucoma and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
March 2020
359 pages
Hepatitis C - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Hepatitis C (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Hepatitis C and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
March 2020
414 pages
Herpes Zoster (Shingles) - Pipeline Review, H1 2020
US$ 2,000.00
... . The Herpes Zoster (Shingles) (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Herpes Zoster (Shingles) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
March 2020
69 pages
Malignant Mesothelioma - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Malignant Mesothelioma (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Malignant Mesothelioma and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
March 2020
1024 pages
Myocardial Infarction - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Myocardial Infarction (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Myocardial Infarction and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
March 2020
362 pages
Peritoneal Cancer - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Peritoneal Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Peritoneal Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
March 2020
1595 pages
Pyelonephritis - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Pyelonephritis (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Pyelonephritis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
March 2020
134 pages
Women Infertility - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Women Infertility (Women's Health) pipeline guide also reviews of key players involved in therapeutic development for Women Infertility and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
March 2020
217 pages
Chemotherapy Induced Anemia - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Chemotherapy Induced Anemia (Toxicology) pipeline guide also reviews of key players involved in therapeutic development for Chemotherapy Induced Anemia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
March 2020
63 pages
Dyskinesia - Pipeline Review, H1 2020
US$ 2,000.00
... . The Dyskinesia (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Dyskinesia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
March 2020
249 pages
Graft Versus Host Disease (GVHD) - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Graft Versus Host Disease (GVHD) (Immunology) pipeline guide also reviews of key players involved in therapeutic development for Graft Versus Host Disease (GVHD) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
March 2020
725 pages
Keratoconjunctivitis sicca (Dry Eye) - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Keratoconjunctivitis sicca (Dry Eye) (Ophthalmology) pipeline guide also reviews of key players involved in therapeutic development for Keratoconjunctivitis sicca (Dry Eye) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
March 2020
320 pages
Neutropenia - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Neutropenia (Hematological Disorders) pipeline guide also reviews of key players involved in therapeutic development for Neutropenia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
March 2020
133 pages
Opium (Opioid) Addiction - Pipeline Review, H1 2020
US$ 2,000.00
... . The Opium (Opioid) Addiction (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Opium (Opioid) Addiction and features dormant and discontinued projects. The guide covers therapeutics under Development ...
March 2020
161 pages
Psoriasis - Pipeline Review, H1 2020
US$ 2,500.00
... releases. The Psoriasis (Immunology) pipeline guide also reviews of key players involved in therapeutic development for Psoriasis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
March 2020
935 pages
Tetanus - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Tetanus (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Tetanus and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
March 2020
94 pages
Acromegaly - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Acromegaly (Hormonal Disorders) pipeline guide also reviews of key players involved in therapeutic development for Acromegaly and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
March 2020
103 pages
Deep Vein Thrombosis (DVT) - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Deep Vein Thrombosis (DVT) (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Deep Vein Thrombosis (DVT) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
March 2020
35 pages
Glomerulonephritis - Pipeline Review, H1 2020
US$ 2,000.00
... And Sex Hormones) pipeline guide also reviews of key players involved in therapeutic development for Glomerulonephritis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
March 2020
303 pages
Post-Polycythemia Vera Myelofibrosis (PPV-MF) - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Post-Polycythemia Vera Myelofibrosis (PPV-MF) (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Post-Polycythemia Vera Myelofibrosis (PPV-MF) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
March 2020
364 pages
Depression - Pipeline Review, H1 2020
US$ 2,000.00
... . The Depression (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Depression and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
March 2020
668 pages
Mild Cognitive Impairment - Pipeline Review, H1 2020
US$ 2,000.00
... . The Mild Cognitive Impairment (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Mild Cognitive Impairment and features dormant and discontinued projects. The guide covers therapeutics under Development ...
March 2020
125 pages
Pulmonary Arterial Hypertension - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Pulmonary Arterial Hypertension (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Pulmonary Arterial Hypertension and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
March 2020
383 pages
Anesthetic Effect - Pipeline Review, H1 2020
US$ 2,000.00
... . The Anesthetic Effect (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Anesthetic Effect and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
March 2020
97 pages
Female Hypoactive Sexual Desire Disorder - Pipeline Review, H1 2020
US$ 2,000.00
... . The Female Hypoactive Sexual Desire Disorder (Women's Health) pipeline guide also reviews of key players involved in therapeutic development for Female Hypoactive Sexual Desire Disorder and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
March 2020
52 pages
Friedreich Ataxia - Pipeline Review, H1 2020
US$ 2,000.00
... . The Friedreich Ataxia (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Friedreich Ataxia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
March 2020
122 pages
Paroxysmal Nocturnal Hemoglobinuria - Pipeline Review, H1 2020
US$ 2,000.00
... . The Paroxysmal Nocturnal Hemoglobinuria (Hematological Disorders) pipeline guide also reviews of key players involved in therapeutic development for Paroxysmal Nocturnal Hemoglobinuria and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
March 2020
124 pages
Chlamydia Infections - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Chlamydia Infections (Infectious Disease) pipeline guide also reviews of key players involved in therapeutic development for Chlamydia Infections and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
March 2020
78 pages
Hyperuricemia - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Hyperuricemia (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Hyperuricemia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
March 2020
82 pages
Male Infertility - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Male Infertility (Male Health) pipeline guide also reviews of key players involved in therapeutic development for Male Infertility and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
March 2020
37 pages
Pancreatic Cancer - Pipeline Review, H1 2020
US$ 2,500.00
... releases. The Pancreatic Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Pancreatic Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
March 2020
3802 pages
Tinnitus - Pipeline Review, H1 2020
US$ 2,000.00
... Nose Throat Disorders) pipeline guide also reviews of key players involved in therapeutic development for Tinnitus and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
March 2020
45 pages
Esophageal Cancer - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Esophageal Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Esophageal Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
March 2020
1342 pages
Thyroid Cancer - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Thyroid Cancer (Oncology) pipeline guide also reviews of key players involved in therapeutic development for Thyroid Cancer and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
March 2020
885 pages
Bacterial Conjunctivitis - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Bacterial Conjunctivitis (Ophthalmology) pipeline guide also reviews of key players involved in therapeutic development for Bacterial Conjunctivitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
March 2020
34 pages
Chemotherapy Induced Peripheral Neuropathy - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Chemotherapy Induced Peripheral Neuropathy (Toxicology) pipeline guide also reviews of key players involved in therapeutic development for Chemotherapy Induced Peripheral Neuropathy and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...
March 2020
151 pages
Gastric Ulcers - Pipeline Review, H1 2020
US$ 2,000.00
... releases. The Gastric Ulcers (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Gastric Ulcers and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies/Universities ...
March 2020
53 pages
Pancreatitis - Pipeline Review, H1 2020
US$ 2,000.00
... Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Pancreatitis - Pipeline Review, H1 2018, provides comprehensive information on the therapeutics under development for Pancreatitis (Gastrointestinal) The guide covers the ...
March 2020
101 pages
